Pipeline Therapeutics pulls in $80m Series C

Pipeline Therapeutics, a biopharmaceutical company, has secured $80 million in Series C financing.

Pipeline Therapeutics, a biopharmaceutical company, has secured $80 million in Series C financing. The investors included Perceptive Advisors, Franklin Templeton, Casdin Capital, Samsara BioCapital, Suvretta Capital and Red Tree Venture Capital.

Source: Press Release